Back

Kaplan Medical Education

  • Multiple Sclerosis
  • Tyrosine Kinase Inhibitors

BTK Inhibitor Slows Disability Progression in MS

What do paramagnetic rim lesions (PRLs) have to do with it? This activity explores recent evidence around the significance of PRLs in multiple sclerosis disease progression, and why certain disease-modifying therapies, like Bruton’s tyrosine kinase inhibitors, may have particular impact on this pathology.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Board review / self-assessment
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    May 19, 2025
  • Last day to claim credit
    Apr 1, 2027 6 months left